<DOC>
	<DOCNO>NCT01552447</DOCNO>
	<brief_summary>The purpose study determine whether EpiFix human amniotic membrane effective treatment venous leg ulcer .</brief_summary>
	<brief_title>Human Amniotic Membrane Grafting Standard Care Versus Standard Care Alone Treatment Venous Leg Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>At least 18 year old Ankle Brachial Pressure Index ( ABI ) &gt; 0.75 Presence venous leg ulcer extend full thickness skin muscle , tendon bone Study ulcer present least one month prior initial screen visit , exclude undergone 12 month continuous high strength compression therapy duration Study ulcer minimum 2 cm2 maximum 20 cm2 Randomization visit The target ulcer treat compression therapy least 14 day prior randomization Ulcer clean , granulate base minimal adherent slough Randomization visit Females childbearing potential must willing use acceptable method contraception ( birth control pill , barrier , abstinence ) . Patient understands willing participate clinical study comply weekly visit followup regimen Patient read sign IRB/IEC approve Informed Consent Form screening procedure undertake Study ulcer ( ) deem investigator cause medical condition venous insufficiency Study ulcer exhibit clinical sign symptom infection . Nonmobile i.e . ambulatory , bed ridden Study ulcer , opinion investigator , suspicious cancer undergo ulcer biopsy rule carcinoma ulcer Patients history two week treatment immunosuppressant ( include systemic corticosteroid ) , cytotoxic chemotherapy , application topical steroid ulcer surface within one month prior initial screening , receive medication screen period , anticipated require medication course study Patients investigational drug ( ) therapeutic device ( ) within 30 day precede Screening History radiation ulcer site Known history Acquired Immunodeficiency Syndrome ( AIDS ) HIV . Study ulcer previously treat tissue engineer material ( e.g . Apligraf® Dermagraft® ) scaffold material ( e.g . Oasis , Matristem ) within last 30 day Study ulcer require negative pressure wound therapy hyperbaric oxygen course trial . Patients unable understand aim objectives trial Presence condition ( ) seriously compromise subject 's ability complete study , know history poor adherence medical treatment NYHA Class III IV congestive heart failure ( CHF ) , define follow criterion : Class III : Symptoms moderate exertion ; Class IV : Symptoms rest Ulcers dorsum foot 50 % ulcer malleolus exclude . Pregnant breast feed Currently take medication could affect graft incorporation . ( supervise physician discretion ) Allergic gentamicin streptomycin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>